Form 4: Shattuck Labs CTO Granted 315,500 Stock Options

Shattuck Labs' Chief Technical Officer, Abhinav A. Shukla, was granted options to purchase 315,500 shares of common stock at an exercise price of $4.75 per share.

Summary

• Abhinav A. Shukla, Chief Technical Officer of Shattuck Labs, Inc. (STTK), was granted options to acquire 315,500 shares of the company's common stock.
• The options have an exercise price of $4.75 per share.
• One quarter of the options will vest on January 10, 2027.
• The remaining three quarters will vest in equal monthly installments through January 10, 2030.
• Vesting is contingent upon Mr. Shukla's continued service to Shattuck Labs, Inc.
• The options have an expiration date of January 10, 2036.

Sentiment

Score: 7

Explanation: The grant of stock options to a key executive aligns management's interests with long-term shareholder value, promoting retention and performance incentives. This is generally a positive signal for corporate governance and executive alignment.

Positives

• The grant of stock options aligns the Chief Technical Officer's long-term incentives with shareholder value.
• The multi-year vesting schedule promotes executive retention and commitment to the company's future performance.

Risks

• The value of the options is subject to the future market price of Shattuck Labs' common stock, which may fluctuate.
• The options will only vest if the reporting person maintains continued service to the issuer, posing a risk of forfeiture if employment ceases.

Future Outlook

The grant of long-term stock options suggests a strategic intent to retain key executive talent and align their performance with the company's long-term growth objectives.

Industry Context

Stock option grants are a standard component of executive compensation packages in the biotechnology and pharmaceutical sectors, designed to incentivize leadership and align their financial interests with the company's long-term success and shareholder returns.

Comparison to Industry Standards

• Stock option grants are a common form of executive compensation in the biotechnology and pharmaceutical industries, aiming to align executive incentives with long-term company performance and shareholder value.
• The vesting schedule over several years is typical for retaining key talent and ensuring sustained commitment to corporate objectives.

Related Party Transactions

• Grant of 315,500 stock options to Abhinav A. Shukla, Chief Technical Officer of Shattuck Labs, Inc., which constitutes a transaction between the company and a related party (an officer).

Stakeholder Impact

• Shareholders: Potential future dilution if options are exercised, but also benefit from aligned management incentives and retention of key talent.
• Employees (specifically Abhinav A. Shukla): Enhanced long-term compensation and incentive to contribute to the company's growth.

Next Steps

• Abhinav A. Shukla will continue to serve Shattuck Labs, Inc. to meet the vesting conditions of the options.
• The options may be exercised by Mr. Shukla upon vesting and prior to their expiration date.

Key Dates

Keywords

Shattuck Labs, STTK, Stock Options, Executive Compensation, Insider Transaction, Form 4, Abhinav A. Shukla, Chief Technical Officer